By Michele Maatouk
Date: Wednesday 14 Jan 2026
(Sharecast News) - Oxford Biomedica confirmed on Wednesday that it has received unsolicited takeover approaches from private equity firm EQT.
In a brief statement in response to recent press speculation, the cell and gene therapy company said it is now in preliminary discussions with EQT "to explore whether a proposal can...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news